Table 2.
Overall results of sentinel node analysis
| Parameter | Histology n = 35,143 | % | OSNA n = 1086 | % | P-value |
|---|---|---|---|---|---|
| Macrometastasis | 4449 | 12.7 | 116 | 10.7 | 0.053 |
| Micrometastasis | 2771 | 7.9 | 162 | 14.9 | < 0.001 |
| Axillary therapy* | 0.083 | ||||
| Yes | 5046 | 14.4 | 155 | 14.3 | |
| No | 29,937 | 85.2 | 931 | 85.7 | |
| Unknown | 160 | 0.5 | 0 | 0.0 | |
| Axillary lymph node dissection | 723 | 2.1 | 60 | 5.5 | < 0.001 |
| Axillary radiotherapy | < 0.001 | ||||
| Yes | 4323 | 12.3 | 95 | 8.7 | |
| No | 30,660 | 87.2 | 991 | 91.3 | |
| Unknown | 160 | 0.5 | 0 | 0.0 | |
| Chemotherapy** | 6655 | 18.9 | 229 | 21.1 | 0.075 |
| Endocrine therapy | 17,852 | 50.8 | 497 | 45.8 | 0.001 |
| Chemotherapy and endocrine therapy | 4873 | 13.9 | 133 | 12.2 | 0.128 |
Significant differences are bold
*Axillary lymph node dissection or axillary radiotherapy
**Chemotherapy with or without (targeted) immunotherapy. Statistical analysis was performed using Pearson Chi-square test